Welcome to CYTAVIS BioPharma GmbH
CYTAVIS, based in Bergisch-Gladbach/Germany, is a product driven oncology company with a focus on natural compounds. The company’s portfolio comprises pre-clinical and clinical programs.
Latest News
Phase II Trial with Aviscumine (CY-503): Metastatic Colorectal Carcinoma
2009-05-12 by Prof. Dr. Lentzen
Phase II trial with Aviscumine (CY-503): Metastatic Melanoma
2009-04-01 by Administrator